Published in Vnitr Lek on November 01, 1976
Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol (1993) 4.39
Perioperative mucosal pH and splanchnic endotoxin concentration in orthotopic liver transplantation. Br J Anaesth (1996) 1.41
[Imatinib mesylate (Glivec) in treatment of chronic phase chronic myeloid leukemia]. Vnitr Lek (2004) 1.39
Does aprotinin affect blood loss in liver transplantation? Lancet (1992) 1.38
Long-term experience with the technique of subclavian and femoral vein cannulation in hemodialysis. Artif Organs (1979) 1.15
Leukocyte kinetics in pulmonary microcirculation: intravital fluorescence microscopic study. J Appl Physiol (1985) (1994) 1.06
The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis--a randomized controlled trial. J Rheumatol (1990) 1.05
Liver retransplantation--indications, frequency, results. Transplant Proc (1992) 0.98
The function of the exocrine pancreas in chronic renal disease. Digestion (1970) 0.90
Results of liver transplantation for gastroenteropancreatic tumor metastases. World J Surg (1996) 0.90
MR imaging of pediatric cardiac tumors previously diagnosed by echocardiography. J Comput Assist Tomogr (1989) 0.89
[Chronic gastritis in young and old persons. Histological and histochemical examination]. Gerontol Clin (Basel) (1966) 0.89
[Heart dislocation following extensive lung resection with partial pericardial resection]. Anaesthesist (1987) 0.87
Pattern-reversal visual evoked potentials in patients with chronic renal insufficiency. Electroencephalogr Clin Neurophysiol (1983) 0.86
Alterations in human thoracic duct lymph in relation to the function of the pancreas. Am J Med Sci (1966) 0.86
The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis--an 8-month followup. J Rheumatol (1994) 0.84
Expression of adhesion molecules on circulating polymorphonuclear leukocytes during orthotopic liver transplantation. Hepatology (1998) 0.84
Effect of blood flow on the leukocyte-endothelium interaction in pulmonary microvessels. Am J Respir Crit Care Med (1995) 0.82
Lung procurement by low-potassium dextran and the effect on preservation injury. Munich Lung Transplant Group. Transplantation (1999) 0.82
Contribution of selectins to leucocyte sequestration in pulmonary microvessels by intravital microscopy in rabbits. J Physiol (1997) 0.81
[An unusual course in hairy-cell leukemia with marked abdominal lymphadenopathy, leukemic infiltration of the cornea and skin changes]. Vnitr Lek (1996) 0.80
[Continuous peridural analgesia vs patient - controlled intravenous analgesia for pain therapy after thoracotomy]. Anaesthesist (2000) 0.80
The significance of soluble CD138 in diagnosis of monoclonal gammopathies. Neoplasma (2006) 0.79
Coagulation properties of human thoracic duct lymph. Am J Med Sci (1967) 0.79
[Sideroblastic anemia after treatment with isoniazid (Nidrazid)]. Vnitr Lek (1974) 0.79
Microhemodynamics and leukocyte sequestration after pulmonary ischemia and reperfusion in rabbits. J Thorac Cardiovasc Surg (1998) 0.79
Cardiopulmonary exercise testing before and after lung and heart-lung transplantation. Am J Respir Crit Care Med (1999) 0.78
[Occurence of cancer in chronic myeloid leukemia]. Vnitr Lek (1977) 0.78
[Tumor microembolization in the lungs--a cause of marked dyspnea, syncope, hemolytic syndrome and disorders of hemocoagulation]. Vnitr Lek (1992) 0.78
Long-term observation of retinal electrical activity in dialyzed and renal transplantation patients. Artif Organs (1984) 0.78
Is there an increased risk of colorectal cancer after cholecystectomy? Neoplasma (1985) 0.77
Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia--distinct subgroups or two stages of the same disease? Leuk Res (2001) 0.77
Leukocyte sequestration in pulmonary microvessels and lung injury following systemic complement activation in rabbits. J Vasc Res (1999) 0.76
The value of bone marrow biopsy in the prognosis of hairy cell leukemia (HCL). Neoplasma (1994) 0.76
The effect of repeated stimulation of the pancreas on the pancreatic secretion in young and aged men. Gerontol Clin (Basel) (1969) 0.76
Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine. Neoplasma (1998) 0.76
[IgA nephropathy, isolated hematuria and renal biopsy]. Vnitr Lek (2003) 0.75
[The effects of aprotinin. Blood loss and coagulation parameters in orthotopic liver transplantation: A clinical-experimental, prospective and randomized double-blind study]. Anaesthesist (1997) 0.75
[Chronic myeloid leukemia and imatinib mesylate therapy]. Vnitr Lek (2004) 0.75
Acute phase protein profiles in hairy-cell leukemia. Study in 50 patients. Effects of splenectomy. Neoplasma (1984) 0.75
[Attempted determination of changes in the liver function in relation to age after a pelentan load]. Cesk Gastroenterol Vyz (1966) 0.75
[Surgical treatment of renal hypertension]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1965) 0.75
[Malignant lymphogranuloma with hypereosinophilia, perforation of the small intestine and presence of Charcot-Leyden crystals]. Vnitr Lek (1976) 0.75
[Iron therapy in patients in the chronic intermittent hemodialysis program (CHIHP)]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl (1981) 0.75
The human thoracic duct lymph. Quantitative and qualitative analysis of the cellular composition of the lymph. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1976) 0.75
[Hemorrhagic manifestations in avitaminosis C]. Vnitr Lek (1969) 0.75
Hairy-cell leukemia and toxoplasmosis. Neoplasma (1982) 0.75
Potassium of erythrocytes and skeletal muscles in patients with uncomplicated congestive heart failure and with cor pulmonale. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1968) 0.75
[Unusual form and course of chronic myeloid leukemia (author's transl)]. Cas Lek Cesk (1980) 0.75
[Problems of centers for dialysis, especially new tasks in connection with the establishment of new centers for treatment of chronic renal insufficiency]. Cas Lek Cesk (1968) 0.75
[Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine]. Vnitr Lek (2000) 0.75
The human thoracic duct lymph in malignant lymphomas. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1976) 0.75
Incidence of Hodgkin's disease in siblings. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1976) 0.75
[Current therapeutic possibilities in chronic renal insufficiency]. Dtsch Gesundheitsw (1968) 0.75
[Chronic myeloid leukemia (present state of knowledge)]. Vnitr Lek (1981) 0.75
[Significance of monitoring the cellular and humoral immunity in patients with chronic lymphocytic leukemia]. Vnitr Lek (1974) 0.75
[New prospects in the treatment of chronic myeloid leukemia and evaluation of present therapeutic procedures]. Vnitr Lek (1981) 0.75
[Fibrinolytic activity in the extraction wound]. Cesk Stomatol (1976) 0.75
Congenital dyserytropoietic anaemia, type II (HEMPAS) in three siblings. Folia Haematol Int Mag Klin Morphol Blutforsch (1980) 0.75
[An overview of new diagnostic principles and methods in hematology and their use in the general care of patients with internal diseases]. Vnitr Lek (1985) 0.75
The degree of bone marrow infiltration in patients with hairy cell leukemia treated with splenectomy compatible with long-term hematological remission. Neoplasma (2001) 0.75
[On the determination of carbonyl hemoglobin in cadaver blood]. Dtsch Z Gesamte Gerichtl Med (1967) 0.75
[Hemorrhage into the central nervous system in hemophiliacs]. Cesk Neurol (1968) 0.75
[Blood coagulation disorder in connection with cesarean section following previous uterine surgery]. Cesk Gynekol (1968) 0.75
Development of acute myeloblastic leukemia in a patient with pernicious anemia. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1969) 0.75
[The artificial kidney and its role in the treatment of renal failure]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1965) 0.75
[Myeloproliferative states]. Vnitr Lek (1980) 0.75
[Hemolytic anemia with anti-N and anti-e autoantibodies]. Vnitr Lek (1981) 0.75
[Electrolyte changes in the plasma, erythrocytes, and in the skeletal muscle in patients with chronic liver diseases]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1968) 0.75
[Di Guglielmo syndrome (erythroleukemia) with dyserythropoiesis in a patient with breast carcinoma treated by irradiation]. Vnitr Lek (1977) 0.75
[The effect of some factors on survival time in chronic myeloid leukemia]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl (1980) 0.75
[The most frequent sites of hemophilic hemorrhages and their frequency]. Vnitr Lek (1970) 0.75
Minimal residual disease, its detection and significance in hairy-cell leukemia. Acta Medica (Hradec Kralove) (1999) 0.75
[Hemorrhagic conditions probably caused by surreptitious use of Pelentan]. Vnitr Lek (1982) 0.75
[Chronic myeloproliferative conditions and chronic myeloid leukemia (new findings and views)]. Vnitr Lek (1987) 0.75
[Successful completion of pregnancy in a patient with the recurrent type of thrombotic thrombocytopenic purpura]. Vnitr Lek (1987) 0.75
[Disorders of coagulation and hemostasis during pregnancy and labor]. Cesk Gynekol (1968) 0.75
[Diagnosis of rejection]. Rozhl Chir (1981) 0.75
[Immunoblastic lymphadenopathy]. Vnitr Lek (1976) 0.75
Immunoglobulin profiles and blood variables in 50 patients with hairy cell leukemia. Effects of splenectomy. Neoplasma (1984) 0.75
[Contribution to the problem of permanent disorders following late gestoses]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1967) 0.75
[Combination of imatinib and anagrelide in treatment of chronic myeloid leukemia in blastic phase]. Vnitr Lek (2006) 0.75
[Involvement of the central nervous system in chronic myeloid leukemia]. Vnitr Lek (1987) 0.75
[Angioimmunoblastic lymphadenopathy with paraproteinemia and the presence of intracytoplasmic crystalloid inclusions with transformation into malignant lymphoma]. Vnitr Lek (1982) 0.75
[Oral surgical care of patients undergoing anticoagulant therapy]. Cesk Stomatol (1980) 0.75
[Bleeding into the floor of the mouth, pharynx and larynx in hemophiliacs]. Vnitr Lek (1967) 0.75
[Application of lyophilization to chemical-toxicological analysis]. Arch Toxikol (1967) 0.75
[Demands of scientific and technical development on personnel, work space and the organization of work. Experience at the First Internal Clinic in Hradec Králové during the past 35 years]. Vnitr Lek (1987) 0.75
[Current possibilities of treatment of chronic renal insufficiency]. Cas Lek Cesk (1968) 0.75
[Eosinophilic leukemia]. Vnitr Lek (1989) 0.75
The Hp, Gc, Gm, Km and beta 2-glycoprotein I genetic variants in hairy cell leukemia: no apparent association. Neoplasma (1985) 0.75
[Antibodies against parietal cells of the gastric mucosa in patients with pernicious anemia]. Cas Lek Cesk (1967) 0.75
[Treatment of acute relapse of chronic myeloid leukemia]. Vnitr Lek (1986) 0.75
[Value of trepanobiopsy of the bone marrow in the diagnosis of myelofibrosis]. Vnitr Lek (1969) 0.75
[Treatment of acute kidney failure caused by obstetrical and gynecological reasons with artificial kidney]. Cesk Gynekol (1968) 0.75
[Fibrinolysis in hemoblastoses]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1968) 0.75
Is factor V Leiden a risk factor for fetal loss? Acta Medica (Hradec Kralove) (1999) 0.75
[Angioimmunoblastic lymphadenopathy]. Vnitr Lek (1980) 0.75
[Economic notes on the dental care for hemophilic patients]. Cesk Stomatol (1975) 0.75